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Abstract 
The future of manned space flight depends on an analysis of the numerous 
potential risks of travel into deep space. Currently no radiation dose limits have 
been established for these exploratory missions. To set these standards more 
information is needed about potential acute and late effects on human physiology 
from appropriate radiation exposure scenarios, including pertinent radiation types 
and dose rates. Cancer risks have long been considered the most serious late 
effect from chronic daily relatively low-dose exposures to the complex space 
radiation environment. However, other late effects from space radiation exposure 
scenarios are under study in ground-based accelerator facilities and have 
revealed some unique particle radiation effects not observed with conventional 
radiations. A comprehensive review of pertinent literature that considers tissue 
effects of radiation leading to functional detriments in specific organ systems has 
recently been published (NCRP National Council on Radiation Protection and 
Measurements. Information Needed to Make Radiation Protection 
Recommendations for Space Missions Beyond Low-Earth Orbit. Report #153, 
Bethesda, MD, 2006). This paper highlights the review of two non-cancer 
concerns from this report: cardiovascular and immunological effects. 
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1. Introduction 
Space exploration is a challenging endeavor requiring an understanding of the 
biological effects of exposure to a constant, relatively low-dose complex radiation 
field in an environment of additional stressors. A recent report by the National 
Council on Radiation Protection and Measurements (NCRP) has 
comprehensively reviewed what is known about space radiation physics and 
transport, dosimetry, biology, and risk assessment methodology (NCRP, 2006) 
and has identified and described major scientific information that is still needed 
by NASA to make radiation protection recommendations for space missions 
beyond Lower Earth Orbit (LEO).  
Ionizing radiations prevalent in space are complex, comprised of a broad range 
of radiation types and energies from cosmic and unpredictable solar sources, 
representing a very diverse range of ionization qualities and biological 
effectiveness. The linear energy transfer (LET) of the potential radiations can 
cover several orders of magnitude from <1.0 keV µm−1 to > several 
100 keV µm−1. Protons are more prevalent and have relatively low-LET values, 
whereas iron ions for example are relatively more rare, but can have high-LET 
values. 
Typically, astronauts and cosmonauts on the International Space Station (ISS) 
receive from 0.5 to 1.2 mSv d−1, with 75% coming from galactic cosmic ray 
(GCR) ions and 25% coming from protons encountered in passages through the 
South Atlantic Anomaly region of the Van Allen belts. The radiation from GCR is 
continuous and at a very low-dose rate, and thus not only cancer, but also non-
cancer effects should be taken into consideration in the evaluation of late effects 
(Schimmerling and Cucinotta, 2006). It is only during large Solar Particle Events 
(SPEs), such as occurred in 1972, that the dose rates rise to above what is 
considered low-dose rate (Parsons and Townsend, 2000). The radiation dose in 
deep space on missions to Mars will be higher than in LEO, due primarily to the 
increased risk of the longer flight times needed for exploratory missions. There is 
insufficient information to explain the basis of biological effectiveness of different 
radiation at inducing late effects in humans at low-dose rates. 
The risk of cancer has long been recognized as a potential adverse late effect 
from exposure to single or multiple doses of ionizing radiation, but with the 
recognition that many biological and physical variables contribute to radiation 
sensitivity (Suit et al., 2007). Studies on the effects of ionizing radiation on the 
risk of specific diseases and aging on atomic bomb survivors have contributed 
significantly to our understanding of radiation effects on life shortening. Several 
years after the bombs were dropped, the Atomic Bomb Casualty Commission-
Radiation Effects Research Foundation (ABCC-RERF) conducted two 
longitudinal studies, the Adult Health Study (AHS) and the Life Span Study 
(LSS). Short-term radiation effects on the Atomic Bomb Survivors (ABS) were not 
all documented, however by the late 1970s, there was little evidence of a 
correlation between radiation exposure and late effects like aging. Only life 
shortening from cancer was observed, and suggestions of radiation-induced 
atherosclerotic diseases and acceleration of aging in the immune system (Sasaki 
et al., 1991) has been confirmed in more recent follow-up studies (Shimizu et al., 
1999). Correlations have also been made with radiation and increased age 
changes in hypertension (Sasaki et al., 2002), and decreased T- and B-cell 
populations (Kusunoki et al., 1988). 
NCRP Report No. 132 (NCRP, 2000) comprehensively reviewed available 
information on the biological effects of individual components of the space 
radiation environment, with a focus on each of the radiation-types prevalent in 
near-Earth missions. NCRP Report No. 153 (NCRP, 2006) has updated the 
review of available information and extended the summary to identify what is still 
needed to make radiation protection recommendations for travel beyond LEO. 
The focus of this paper is to highlight key research issues raised in NCRP Report 
No. 153 that require further research before deep space missions can be safely 
planned. In particular, radiation effects on the cardiovascular and immune 
systems of the body are highlighted. 
2. Cardiovascular disease 
2.1. Radiation-induced vascular change 
Cancer and diseases of the cardiovascular system account for the majority of 
human deaths. Based on the experience of the ABS cohort who received 
relatively low to intermediate radiation exposures, it has become increasingly 
evident that this radiation-exposed population is susceptible to chronic 
multifactorial diseases including coronary heart disease, essential hypertension, 
and diabetes mellitus (Sankaranarayanan et al., 1999). These pathological 
effects can lead to non-cancer mortalities ([Kodama et al., 1996], [Shimizu et al., 
1999], [Wong et al., 1999] and [Preston et al., 2003]), or at radiation doses below 
those causing increased mortality, simply a reduced quality of life. 
Vascular damage due to radiation exposure has been previously reported. Yang 
and Tobias (1984) irradiated one-day-old neonatal rats in the head region alone 
with either X-rays or heavy ions. Doses ranged from 0.5 to 8 Gy. Distinct 
petechial hemorrhages developed in the cerebral cortex within a few hours after 
irradiation, reached a maximum about 13–24 h, and decreased exponentially 
with time. No brain hemorrhage was found in neonatal rats 12 days after 
irradiation. These results indicated that a dose of a few Gy of X-rays can induce 
a significant number of hemorrhages in the young brain, and the number of 
lesions increased exponentially with dose. Heavy ions induced more 
hemorrhages than X-rays for a given dose, and the RBE for 670 MeV/nucleon 
neon particles ranged from about 2.0 for low-doses to about 1.4 for high doses. 
Histological examination of the hemorrhages revealed that a large number of red 
blood cells leaked from the blood vessels, indicating that the radiation-induced 
hemorrhages may be a result of some capillary membrane damages or 
reproductive death of some blood vessel endothelial cells. The rapid onset of 
hemorrhage after irradiation suggests that some membrane damage may be 
involved. Effects of negative pi mesons on vascular permeability of brain in 
neonatal rats had previously been reported by Landolt et al. (1979). Dose–
response relationships were developed for effects on vascular permeability in 
neonatal rats. The brains were removed and fixed in formalin 24 h after 
irradiation, and scored from 0 to 5 by number and size of petechial hemorrhage. 
The RBE was found to be 1.1 for peak and 0.6 for plateau negative pi mesons 
(peak to plateau ratio of 1.8 compared with 200 kV X-rays). Interestingly, Yang 
and Tobias (1984) found that hesperetin, a compound of vitamin P, may reduce 
the formation of brain hemorrhages in X-ray-irradiated rats. Neonatal rats that 
received a subcutaneous injection of 10 mg hesperetin (dissolved in propylene 
glycol) about 20–30 min before X-ray irradiation showed fewer hemorrhages in 
the brain than those in rats that were only irradiated. Control animals receiving 
the same volume of propylene solution without hesperetin did not show the 
protection. Late effects of heavy charged particles or neutrons on the fine 
structure of the mouse coronary artery have been evaluated by Yang and 
Ainsworth (1982) and Yang et al. (1978), and revealed significantly altered tissue 
morphologies and damage compared to low-LET radiations. A single dose of 
only 0.2 Gy 20Ne ions produced significant damage to the smooth muscle cells in 
the coronary arteries. The major changes included medial smooth muscle 
degeneration, fibrosis, accumulation of debris, and extracellular matrix. 
The development of late somatic lesions in most normal tissues of irradiated 
mammals has been suggested to be a result of vascular damage, although the 
true importance of vascular versus parenchymal cell changes is still not well 
understood (Hopewell, 1980). The heart muscle itself is very radioresistant, with 
anatomical changes not observed below 100 Gy. In contrast, the capillaries have 
been found to be very sensitive to radiation with increased capillary permeability 
in human skin noted after 1 Gy (Neumayr and Thurnher, 1952). But what about 
vascular effects at lower particle fluences? (Griem, 1989) and (Griem et al., 
1994) and Dimitrievich et al. (1984) developed a tandem scanning confocal 
microscope (TSCM) to image the capillary network and the surrounding collagen 
architecture in the papillary dermis of the rabbit ear in vivo after exposure to 
single X-ray doses of 0.5–4 Gy. Serial observations of the microvasculature 
volume and vascular width were digitally analyzed over a several week period 
after the exposure. The 0.5 Gy dose showed transient increases in the width of 
the response that reached a maximum at 20 days post-exposure, and persisted 
out 50 days. At 4 Gy the vessel width shrank by 2 days after exposure. Particle 
beam effects on this endpoint are unknown. 
Since 1899 radiation injury to blood vessels was recognized as one of the most 
common effects of therapeutic radiation on normal human tissues (Fajardo and 
Berthrong, 1988). Alterations in capillaries and arterioles are pathologic 
hallmarks of delayed damage in many mammalian tissues, primarily thought due 
to ischemia resulting from microvascular damage. The narrowest (and most 
prevalent element) of the vasculature is the most radiosensitive due to 
endothelial radiosensitivity and the fact that endothelial cells constitute the major 
component of the walls of the smallest vessels. 
2.2. Radiation-induced atherosclerotic effects 
Atherosclerosis is a multistep process involving injury to the endothelial lining of 
the arteries, infiltration of arterial intima with plasma lipoproteins, migration of 
smooth muscle cells (SMCs) from the media into the intima, proliferation of 
SMCs, and synthesis of connective tissue components. Monocytes in the 
peripheral blood become fat-filled foam cells through the uptake of low-density 
lipoproteins (LDL), and high LDL cholesterol is an important risk factor. 
Radiation-induced coronary disease in humans results in luminal narrowing 
([Stewart et al., 1995] and [Virmani et al., 1999]). The morphological changes are 
different from typical atherosclerosis with more frequent medial destruction and 
greater adventitial fibrosis and thickening produced post-radiation. These 
pathological findings are similar to late radiation-induced tissue changes such as 
areas of necrosis, foam cell deposition, adventitial thickening, and medial 
thinning and calcification which were only observed in porcine arteries with a 
stent coated with a radionuclide. 
Ionizing radiation is reported to accelerate aortic lesion formation in fat-fed mice 
via superoxide dismutase (SOD)-inhibitable processes (Tribble et al., 1999) in a 
dose-dependent manner. The atherogenic effects of radiation appear to be 
particularly pronounced when the high-fat diet was introduced within 7 days after 
exposure to radiation. The mean lesion area was the same as that in the control, 
non-irradiated, high-fat-fed group if the high-fat diet was introduced 14 days after 
exposure. The primary mechanisms by which radiation promotes atherosclerosis 
have not been identified, but based on the premise that atherogenic effects of 
radiation may involve reactive oxygen species (ROS)-mediated promotion of 
lipoprotein oxidation and vascular inflammation, Tribble et al. (1999) 
demonstrated that overexpression of the anti-oxidant enzyme Cu–Zn SOD 
reduced radiation-induced atherosclerotic lesions, and aortic oxygen 
concentrations. Tribble et al. (2000) found evidence that ionizing radiation 
promotes changes in the artery wall that enhance the deposition of lipoprotein 
lipids. Using a trapped ligand methodology, they showed that the LDL is 
degraded more readily in the irradiated aorta and that the enhanced degradation 
is affected by anti-oxidants, including α-tocopherol. These results show that LDL 
degradation products accumulate in the irradiated aorta, but the effect is inhibited 
by anti-oxidants which reduce the potential for LDL oxidation. The radiation used 
for these studies was 60Co γ rays at a dose of 2, 4, or 8 Gy. No data are available 
at lower photon doses, or for HZE particles. Additional research is needed on the 
late radiation effects of low-doses of radiation types prevalent in space on the 
pathophysiology of coronary artery disease, and the potential inhibition of these 
effects by anti-oxidants and low-fat diets. 
Radiation induces several types of damage to the cardiovascular system 
(Basavaraju and Easterly, 2002). X-rays induced changes in gene expression 
and distribution of atrial natriuretic peptide (ANP) in different anatomical regions 
of the heart after acute high doses (15 or 20 Gy) (Kruse et al., 2002). The ANP 
peptide is associated with a variety of morphological changes in the atria and 
ventricules, eventually leading to impairment of cardiac function. Circulating 
levels of ANP in the plasma may provide indications of early cardiac changes. No 
data exist on the effects of exposure to radiations in space on ANP plasma 
levels. 
2.3. CVD in radiotherapy patients and radiation workers 
Several groups of radiation-exposed human populations have shown evidence of 
increased cardiovascular disease (CVD) after relatively high doses (5–50 Gy) of 
low-LET radiations, including radiotherapy patients with breast cancer (Seddon et 
al., 2002), head and neck cancer ([McGuirt et al., 1992] and [Cheng et al., 
1999]), Hodgkin’s disease (Thomson and Wallace, 2002) and testicular cancer 
(van den Belt-Dusebout et al., 2006). There is also an observable excess relative 
risk for CVD among the ABS (Wong et al., 1999) and Chernobyl workers (Ivanov 
et al., 2001). The effects of radiation on the long-term trends of the total serum 
cholesterol levels of the Hiroshima and Nagasaki atomic bomb survivors were 
examined using data collected in the adult Health Study over a 28-year period 
(1958–1986). The growth-curve method was used to model the longitudinal age-
dependent changes. The mean growth-curve of cholesterol levels for the 
irradiated subjects were significantly higher than for the unirradiated subjects, 
and the increase was greater for women than for men. No difference in dose 
response was detected between Hiroshima and Nagasaki. The maximum 
predicted increase at 1 Gy for women occurred at age 52 years for the 1930 
cohort. The corresponding increase for men occurred at age 29 years for the 
1940 cohort. The dose range of exposure for the Chernobyl workers and 
liquidators was 0.005–0.3 Sv. It has been estimated that the liquidators have an 
excess relative risk per unit dose (ERR Sv−1) for CVDs of arteries, arterioles and 
capillaries of 0.54 (0.18, 0.91, 95% CI) derived using an external control based 
on the mortality of the general population in Russia (Ivanov et al., 2001). 
Newly discovered is the statistically significant dose risk of ischemic heart 
disease in Chernobyl emergency workers [Excess Relative Risk (ERR) 
Gy−1 = 0.41, 95% CI = (0.05; 0.78)] (Ivanov et al., 2006). Confirmation is provided 
for the existence of significant dose risks for essential hypertension [ERR 
Gy−1 = 0.36, 95% CI = (0.005; 0.71)], and cerebrovascular diseases [ERR 
Gy−1 = 0.45, 95% CI = (0.11; 0.80)]. In 1996–2000, the assessed ERR Gy−1for 
cerebrovascular diseases was 0.22 with 95% CI = (−0.15; 0.58). Special 
consideration is given to cerebrovascular diseases in the cohort of 29,003 
emergency workers who arrived in the Chernobyl zone during the first year after 
the accident. The statistically significant heterogeneity of the dose risk of 
cerebrovascular diseases is shown as a function of the duration of stay in the 
Chernobyl zone: ERR Gy−1 = 0.89 for durations of less than six weeks, and ERR 
Gy−1 = 0.39 on average. The at-risk group with respect to cerebrovascular 
diseases are those who received external radiation doses >150 mGy in less than 
six weeks [Relative Risk (RR) = 1.18, 95% CI = (1; 1.40)]. For doses >150 mGy, 
the statistically significant risk of cerebrovascular diseases as a function of 
averaged dose rate (mean daily dose) was observed: ERR per 100 mGy 
d−1 = 2.17 with 95% CI = (0.64; 3.69). The duration of the stay within the 
Chernobyl zone itself, regardless of the dose factor, had little influence on 
cerebrovascular disease morbidity: ERR week−1 = −0.002 with 95% CI = (−0.004; 
−0.001). The radiation risks in this large-scale cohort study were not adjusted for 
recognized risk factors such as excessive weight, hypercholesterolemia, 
smoking, alcohol consumption, and others. A systematic review of the 26 
published epidemiological data <5 Sv however, has concluded that other than the 
ABS, the US radiological technologists, the Three Countries Study, and the 
Study of Chernobyl emergency workers, no other published work has the 
statistical power to conclude a risk of circulatory diseases from ionizing radiations 
<4 Sv (McGale and Darby, 2005). No trend in risk of circulatory diseases with 
increasing cumulative exposure to either radon, external gamma radiation, or 
long-lived radionuclides was observed in a German uranium minors cohort study 
with data over 52 years (Kreuzer et al., 2006). 
2.4. Enhanced long-term CVD-related inflammatory responses in 
A-bomb survivors 
Recent evidence points to significant increases in inflammatory activity 
demonstrable in long-term A-bomb survivors which may lead to increased risk of 
CVD and other non-cancer diseases (Hayashi et al., 2003). The inflammatory 
markers C-reactive protein (CRP) and interleukin 6 (IL-6) were significantly 
increased in the plasma of A-bomb survivors by 28% after a 1 Gy exposure for 
CRP and by 9.8% for IL-6, after adjustments for other causative factors such as 
age, body mass index and history of myocardial infarction. The elevated levels of 
these proteins were associated with decreases in the percentages of CD4+ 
helper T-cells in peripheral blood lymphocyte populations. The association with 
increased CVD risk in this cohort is not proved, but appears likely. Clearly, 
information about the long-term effects of ionizing radiation on CVD in humans is 
needed. 
2.5. Countermeasures to radiation-induced CVD 
Radioprotection of normal vascular endothelium with synthetic aminothiols (such 
as WR-2721, and WR-1065) has been reported ([Warfield et al., 1990] and 
[Mooteri et al., 1996]). Presumably the aminothiols are scavenging free radicals 
and aiding the repair of damaged macromolecules. Mooteri et al. (1996) also 
suggest that endothelial cell division and morphology are affected by WR-1065. 
Drab-Weiss et al. (1998) showed that WR-1065 attenuated the inhibition of DNA 
synthesis caused by lipopolysaccharide exposure by promoting DNA synthesis 
and lowering apoptosis in the endothelium. Vitamins E and C are also thought to 
radioprotect the endothelium (Fajardo and Stewart, 1973). Treatment with certain 
growth factors such as fibroblast growth factor-2 (FGF-2) can significantly 
decrease radiation-induced blood vessel stenosis (Fuks et al., 1994). 
3. Hematological changes 
3.1. Effects on blood cell compartments 
Studies on the effects of whole-body proton irradiation on bone-marrow-derived 
cell types and the highly immunosuppressive cytokine transforming growth 
factor-β1 (TGF-β1) have been reported by Kajioka et al. (2000a). C57BL/6 
female mice were irradiated with a single 3 Gy dose of either 250 MeV or mid-
peak stopping protons of 149 MeV. Control animals were irradiated with 3 Gy 
60Co γ-rays. Animals were euthanized in a time course of 0.5, 4, 7, 10, 14, and 
17 days after exposure. Highly significant decreases in white blood cell (WBC) 
counts were noted as early as 12 h post-exposure in all irradiated groups, with 
means being only 32–35% of those for non-irradiated controls. At this same time 
point, significantly low numbers of lymphocytes (11–17% of control), and 
monocytes (32–36% of control) were present. The depression generally 
persisted until the end of the study. 
In contrast, neutrophil levels tended to be erratic, and significant differences were 
observed among the irradiated groups on days 4 and 7. Eosinophils and 
basophils were noted only rarely in all four groups. Red blood cell (RBC) counts 
were significantly decreased at 12 h only in the 60Co-irradiated, but not the 
proton-irradiated animals and the unirradiated control groups. Thrombocyte 
counts fluctuated showing significant depression for all radiation groups on days 
4 and 10–17, but normal levels on days 0.5 and 7. TGF-β1 levels in plasma were 
significantly elevated at 7 days post-exposure in mice irradiated with 60Co when 
compared to non-irradiated controls or to either of the proton-irradiated groups. 
However, by day 17 all irradiated groups had significantly lower levels of the 
cytokine than did the control animals. 
Dose and dose-rate effects of whole-body γ-irradiation have been reported for 
lymphocytes and lymphoid (Pecaut et al., 2001) and hematological variables and 
cytokines (Gridley et al., 2001). C57BL/6 mice were exposed to 0, 0.5, 1.5, and 
3 Gy at a low-dose rate (LDR) of 10 mGy min−1, or at a high-dose rate (HDR) of 
800 mGy min−1 and euthanized 4 days later. A significant dose-dependent loss of 
spleen mass was observed with both LDR and HDR irradiation; whereas for the 
thymus this was only true with HDR. Decreasing leukocyte and lymphocyte 
numbers occurred with increasing dose in blood and spleen at both dose rates. 
The numbers of CD3+ T lymphocytes decreased in the blood in a dose-
dependent manner at both HDR and LDR. Splenic T-cell counts decreased with 
dose only in HDR groups; percentages increased with dose at both dose rates. 
Dose-dependent decreases occurred in CD4+ T helper and CD8+ T cytotoxic cell 
counts at HDR and LDR. In the blood, the percentage of CD4+ cells increased 
with increasing dose at both dose rates, whereas in the spleen the counts 
decreased only in the HDR groups. The percentages of the CD8+ population 
remained stable in both blood and spleen. CD19+ B-cell counts and percentages 
in both compartments declined markedly with increasing HDR and LDR radiation. 
Natural killer cell (NK1.1+) numbers and proportions remained relatively stable. 
Overall, these data indicate that the observed changes were highly dependent on 
the dose, but not dose rate, and cells in the spleen are more affected by dose 
rate than those in blood. The results also suggest that the response of 
lymphocytes in different body compartments may be variable. Significant dose- 
(but not dose-rate-) dependent decreases were observed in erythrocyte and 
blood leukocyte counts, hemoglobin and hematocrit. 
4. Immune deficiencies 
The immune system is affected by a number of stressors including exposure to 
radiation and microgravity. A brief description of the effects of radiation alone is 
provided here, as well as a brief summary of the combined effects of microgravity 
and radiation on the immune system. 
The study of low-dose (<1.5–2 Gy administered in numerous low-dose fractions 
of 0.1–0.25 Gy) low-LET radiation effects on the immune system is important, but 
its therapeutic value in inducing long-term remissions of tumor by stimulating the 
immune system has been controversial (Safwat, 2000). Numerous signs of 
immune system dysfunction in radiation-exposed populations have been 
reported. Since an impaired immune system promotes disease progression, and 
initiation, both acute and late effects of radiation on the immune system have 
been investigated. Kusunoki et al. (2001) found that the reduction in the PHA 
response in heavily irradiated atomic bomb survivors is dependent on a decrease 
in IL2-producing CD4 T-cells. When exogenous IL2 was added to the peripheral 
blood lymphocytes of the heavily exposed individuals, the proliferative response 
to the mitogen was restored. In a follow-up study, the T-cells of Atomic Bomb 
Survivors who received doses between <0.005 and 1 Gy were found to respond 
poorly to stimulation by Staphylococcus aureus toxins in vitro. The results clearly 
indicated that A-bomb irradiation led to an impairment of the ability of exposed 
individuals to maintain their native T-cell pools ([Kusunoki et al., 2002a], 
[Kusunoki et al., 2002b] and [Hayashi et al., 2003]). 
Immunophenotyping of PHA-activated mononuclear cells (MNCs) in Chernobyl 
liquidators who received between 150–500 mGy 13 years prior showed impaired 
T-cell function, but currently are healthy. Suppression of CD8+ T-cell propagation 
and augmentation of CD8+ T-cell propagation in vitro were both noted compared 
to control individuals (Kuzmenok et al., 2003). DNA synthesis in the MNCs was 
markedly inhibited after activation for 3 days with suboptimal concentrations of 
PHA, pokeweed mitogen and PMA. In contrast to control individuals, the 
monocytes of cleanup workers were able to stimulate the proliferation of T-cells 
from healthy individuals but inhibited the proliferation of T-cells from cleanup 
workers. Two recent papers have examined the acute effects of iron-particle 
radiation on immunity in population distributions (Pecaut et al., 2006), and with 
regard to leukocyte activation, cytokines, and adhesion (Gridley et al., 2006). 
Both papers indicate significant dose-dependent changes in cell-based immunity 
4 days following single doses of 2 or 3 Gy, with fewer effects observed at 0.5 Gy. 
Kajioka et al. (1999) compared the effects of proton and 60Co-γ radiation on cell-
mediated and humoral immunological parameters. C57BL/6 mice were exposed 
to a single dose of 3 Gy protons (mid-peak of 3-cm 149 MeV protons) or γ-rays 
and intraperitoneally injected 1 day later with sheep red blood cells (sRBC). 
Subsets from each group were euthanized (along with non-irradiated controls 
with and without the sRBC injection) in a time course 4, 10, 15, and 29 days after 
exposure. Body and relative spleen weights, leukocyte counts, spontaneous 
blastogenesis, lymphocyte populations, and anti-sRBCC titers were evaluated. 
The data showed that whole-body irradiation with protons, or γ-rays at this 
relatively high-dose resulted in marked, but transient immunosuppression in 
nearly all assays involving leukocyte populations as well as the spleen. On days 
4 and 10 after irradiation B lymphocytes (CD19+) were the most radiosensitive, 
although reconstitution back to normal levels was observed by day 15. T-cell 
(CD3+) and T helper cell (CD4+) recovery was evident by day 29, whereas the T 
cytotoxic cell (CD8+) count remained significantly below normal. NK1.1+ were 
relatively radioresistant. Anti-sRBC antibody production was slow and low titers 
were obtained after irradiation compared to the unirradiated controls. However, 
overall, no significant differences were noted between the two types of radiation. 
Kajioka et al. (2000b) report little differences with higher energy protons at the 
entrance of the 250 MeV proton beam, compared to the mid 3 cm peak 149 MeV 
proton energy. Gridley et al. (2002), however have reported the effects of 0.1, 
0.5, and 2 Gy iron ions on lymphoid cells and organs of C57B/6 mice days 4 and 
113 after whole-body exposure. The data collectively show that lymphoid cells 
and tissues are markedly affected by high-LET radiation at relatively low-doses, 
that some changes persist long after exposure, and that different consequences 
may be induced by various densely-ionizing particles. The authors conclude that 
simultaneous exposure to multiple radiation sources could lead to a broader 
spectrum of immune dysfunction than currently anticipated. 
There is a major need to investigate the effects of exposure to low-LET radiations 
at lower doses and dose-rates. Only a very small literature could be found on the 
effects of exposure to heavy particle beams on the immune system. This is a 
serious deficiency. The combined hazards of exposure to radiation and 
microgravity are also a potential issue. 
4.1. Combined microgravity and radiation effects 
Space flight affects immune function ([Sonnenfeld, 1998] and [Sonnenfeld, 
2001]) in astronauts exposed to the conditions of long-term space flight and its 
rigors of isolation, containment, microgravity, radiation, microbial contamination, 
sleep disruption, and insufficient nutrition. In a review article, Sonnenfeld and 
Shearer (2002) summarized information gleaned from both in vitro and in vivo 
studies. Early human studies indicated that space flight changed human cell 
culture activities, such as leukocyte blastogenesis ([Cogoli et al., 1980], [Cogoli 
et al., 1984], [Bechler et al., 1992] and [Cogoli, 1993]), production of cytokines 
([Talas et al., 1983] and [Bechler et al., 1992]) and signal transduction in 
leukocytes ([Limouse et al., 1991] and [Schmitt et al., 1996]). Studies on animal 
cell cultures have shown alterations in cytokine production (Chapes et al., 1992), 
and macrophage hematopoiesis and function (Armstrong et al., 1995). There is 
also a recent report of changes in neutrophil functions in astronauts (Kaur et al., 
2004). The study indicates that neutrophil phagocytosis and oxidative functions 
are affected by factors associated with space flight and this relationship may 
depend on mission duration. Decreased non-MHC-restricted (CD56+) killer cell 
cytotoxicity has also been reported in astronauts after spaceflight (Mehta et al., 
2001). 
The effects of microgravity on leukocyte blastogenesis were very intriguing. 
Leukocytes from astronauts were placed in culture during a Space Shuttle 
mission, and challenged with a mitogen to induce cell division (or blastogenesis). 
Blastogenesis of leukocytes is a requirement for a functional immune response. 
The leukocyte blastogenesis in flight was dramatically decreased compared to 
ground controls, or 1 g controls centrifuged in space flight. This was among the 
first demonstrations that microgravity could affect cell culture in space flight. 
However, when the cells were immobilized on beads, allowing lymphocytes 
undergoing division during blastogenesis to interact with accessory macrophages 
required for blastogenesis, the blastogenesis proceeded in a normal fashion. 
This led to the observation that factors that occur in space flight conditions other 
than microgravity, such as changes in shear stress and fluid dynamics that would 
interfere with interactions between cells, also play a role in the effects of space 
flight on leukocyte blastogenesis (see (Sadhal, 2002) for an overview). 
In vivo studies of effects of microgravity on the immune system have not always 
yielded results similar to those data obtained in vitro. Talas et al. (1983) had 
cosmonauts in space flight obtain and culture leukocytes, and then challenged 
the cultures to produce interferon-α/β. The interferon production was greatly 
enhanced compared with controls. However, when the same cosmonauts who 
had donated the cells used for cultures in space had leukocyte samples 
challenged after they returned from space, interferon-α/β production was 
dramatically decreased compared with controls. The lymphocytes in culture 
would have experienced different fluid shear forces as well as a lack of 
neuroendocrine signals compared to the lymphocytes in vivo (Sonnenfeld and 
Shearer, 2002). 
Early ground studies on immune function in mice maintained in an environment 
in which barometric pressure was altered in a similar way to space flight, 
revealed greater susceptibility to mengovirus infection than did mice maintained 
under normal barometric pressure conditions (Giron et al., 1967). Hind-limb 
unloading (anti-orthostatic 15°–20° head-down tilt, with hypokinetic, and 
hypodynamic-no load-suspension by raising the tail, or suspension with a 
harness) has been an effective model for some conditions that occur during 
space flight (e.g., Ilyin, 2000). With this model, muscle, and bone changes occur 
that are similar to those after exposure to microgravity in the space flight 
environment. Involution of the thymus also occurs, but does not appear to have 
an effect on antibody production ([Caren et al., 1980] and [Steffen and 
Musacchia, 1986]). 
Rats and mice have been used to investigate the effects of hind-limb unloading 
on cell-mediated immunity (Steffen et al., 1984). Interferon-α/β production was 
severely inhibited in rats and mice subjected to hind-limb unloading ([Sonnenfeld 
et al., 1982] and [Rose et al., 1984]). The mice required the head-down tilt for the 
inhibition effect to be seen, whereas the rats did not. The mice and rats regained 
the ability to produce interferon when they were allowed to recover in normal 
caging conditions. Interferon-γ production by spleen cells of hind-limb-unloaded 
rats also was inhibited (Berry et al., 1991). Numerous studies have investigated 
how the hind-limb unloading model of microgravity affects the ability to combat 
infection. Evidence such as decreased production of superoxide and impaired 
killing of phagocytosed bacteria (Fleming et al., 1990), susceptibility to 
encephalomyocarditis virus D variant which correlated with the loss of interferon, 
and other pathogens ([Gould and Sonnenfeld, 1987], [Miller and Sonnenfeld, 
1993], [Miller and Sonnenfeld, 1994] and [Belay et al., 2002]) led to the 
conclusion that the hind-limb unloading model correlated to actual alterations in 
resistance to infection in space travel and can even lead to mortality. This is 
potentially a serious issue since threats to health normally combated by the 
immune system are enhanced in space flight due to a combination of enclosed 
environment and low gravity which can promote the growth of bacteria (Todd et 
al., 1999). 
Sonnenfeld and Shearer have summarized effects of space flight on the immune 
system that have been observed from both studies in vitro and in vivo that 
followed the hind-limb unloading ground-based studies. The results of human 
studies are very limited. Human ground-based models of space flight can mimic 
some of the conditions that occur during space flight, but none can re-create all 
space flight conditions. Delayed hypersensitivity skin test responses to common 
recall antigens which are a measure of cellular immune system function were 
determined during space flight and were found to be inhibited during short-term 
and long-term space flights ([Taylor and Janney, 1992] and [Gmunder et al., 
1994]). Recent studies in humans have investigated the effects of space flight on 
herpes virus and Epstein-Barr virus reactivation and have shown increases in 
urinary catecholamine excretion ([Stowe et al., 2001a] and [Stowe et al., 2001b]). 
Persistent viruses have been associated with non-Hodgkin’s lymphoma tumors 
(Vilchez et al., 2002) and raise concerns with regard to susceptibility of crew 
members to cancer. A short-term space flight study on the Space Shuttle showed 
no change in total immunoglobulin levels of astronauts compared with ground-
based controls (Voss, 1984), but long-term space flight on a Soviet mission has 
indicated small increases in total immunoglobulin levels (Konstantinova and 
Fuchs, 1991). Significant levels of research on the effects of space flight on the 
antibody response to specific antigens have not yet been done, and are definitely 
needed to determine the true sensitivity of antibody responses to space flight 
conditions. 
5. Summary 
The published literature on the effects of low-doses of radiation on cardiovascular 
and immunological systems of the human body are primarily based on what has 
been observed in atomic bomb survivors, radiotherapy patients, radiation 
workers and radiation accidents. It is becoming increasingly evident that 
individuals exposed to low-dose radiation exposures can in addition to cancer, be 
susceptible to chronic multifactorial diseases including coronary heart disease, 
essential hypertension, and changes in immune competence. Additional new 
information is coming from the laboratory using animal models and accelerator-
based radiation exposures, but there is currently very little data upon which to 
base estimates of radiation dose limits for protection from adverse acute and late 
effects on cardiovascular and immune function due to deep space radiation 
exposure scenarios. The effects of additional stressors in space such as 
microgravity, and catecholamines triggered by working conditions in space may 
independently impact cardiovascular and immune tissues, and present 
confounding factors to the analysis of radiation-induced effects. It is important to 
understand the mechanisms underlying these physiological effects in order to set 
appropriate dose limits during deep space travel, and in order to devise 
appropriate countermeasures to prevent loss in the quality of life during and 
following deep space missions. 
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